The authors noted that the available studies allowed only for indirect comparison among the different anti-TNF agents. Therefore, they were unable to make a conclusion about the differences among the drugs with regard to key benefit or harm outcomes. (posted 5/8/15)
Dr. Pullen is a medical writer based in the Chicago area.
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE